Genito-Pelvic Pain/Penetration Disorder Clinical Trial
Official title:
Graded Motor Imagery in Women Diagnosed With Genito-Pelvic Pain Penetration Disorder. A Randomized Controlled Trial
| Verified date | May 2024 |
| Source | University of Valencia |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Interventional |
The goal of this clinical trial is to assess the effects of a Graded Motor Imagery (GMI) programme in women diagnosed with Genito-Pelvic Pain Penetration (GPPD) Disorder. The main questions it aims to answer are: Does a GMI programme reduce pain intensity levels in women diagnosed with GPPPD? Does a GMI programme have an effect on sexual function in women diagnosed with GPPPD? Participants will undergo a GMI programme and will be tested prior to and after the intervention to assess if the programme has a significant effect with regards to pain intensity and other pain-related outcome
| Status | Completed |
| Enrollment | 96 |
| Est. completion date | July 22, 2023 |
| Est. primary completion date | July 15, 2023 |
| Accepts healthy volunteers | No |
| Gender | Female |
| Age group | 18 Years and older |
| Eligibility | Inclusion Criteria: - Women diagnosed with persistent pelvic pain - Pain suffered for a period of a minimum of 3 months - Adult (>18 years) women Exclusion Criteria: - Medical condition that logically explains the presence of pain - Pain suffered for a period of less than 3 months |
| Country | Name | City | State |
|---|---|---|---|
| Spain | University of Valencia | Valencia |
| Lead Sponsor | Collaborator |
|---|---|
| University of Valencia |
Spain,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Pain Intensity | Pain intensity assessed through a Visual Analogue Scale, with a mininum value of 0 and a maximum value of 10, higher scores mean a worse outcome | 6 weeks | |
| Primary | Sexual function | Sexual function assessed through a short version of the Female Sexual Function Index (FSFI). Minimum score is 6, maximum score is 30. Higher scores mean better outcome. | 6 weeks |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Terminated |
NCT03682601 -
Sexual Penetration Pain in Postmenopausal Women: A Topical Botanical Drug Treatment
|
Phase 2 | |
| Completed |
NCT05857826 -
Soft Tissue Release With and Without Vaginal Dilators on Pain and Sexual Function in Genitio Pelvic Pain
|
N/A |